These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1972296)

  • 1. The role of mesalazine in Crohn's disease.
    Hanauer SB
    Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of symptomatic remission in patients with Crohn's disease.
    Stark ME; Tremaine WJ
    Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer?
    Tremaine WJ
    Gastroenterology; 1992 Aug; 103(2):694-6. PubMed ID: 1353043
    [No Abstract]   [Full Text] [Related]  

  • 6. Is maintenance therapy effective in Crohn's disease?
    Greenberger NJ; Miner PB
    Lancet; 1994 Oct; 344(8927):900-1. PubMed ID: 7934340
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR; Mays DA
    Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM; Duncan A; Russell RI
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: maintenance treatment of Crohn's disease.
    Biancone L; Tosti C; Fina D; Fantini M; De Nigris F; Geremia A; Pallone F
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():31-7. PubMed ID: 12786610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
    Martin F
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalazine as maintenance treatment in Crohn's disease.
    Vos J; Lesterhuis W
    Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG
    Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
    van Hees PA
    Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
    Singleton JW; Hanauer SB; Gitnick GL; Peppercorn MA; Robinson MG; Wruble LD; Krawitt EL
    Gastroenterology; 1993 May; 104(5):1293-301. PubMed ID: 8482443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
    Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
    Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.